VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1787489
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: SCRATCH; RED; SORE; A spontaneous report has been received from a consumer. The report concerns a patient of unknown gender of Unknown ethnic origin born in 1998. No medical history was reported. No concomitant products were reported. The patient received Flumist Quadrivalent (influenza vaccine live reassort 4v), via nasal route, on an unknown date. No malfunction has been reported for FLUMIST QUADRIVALENT. On an unknown date, the patient experienced scratch (preferred term: Scratch). On an unknown date, the patient experienced red (preferred term: Erythema). On an unknown date, the patient experienced sore (preferred term: Pain). Treatment with Flumist Quadrivalent (influenza vaccine live reassort 4v) was not changed. At the time of reporting, the event of scratch, red and sore was ongoing. The events were considered non-serious. The reporter did not consider that there was a reasonable possibility of a causal relationship between Flumist Quadrivalent and the following event: red, scratch and sore. The company physician did not consider that there was a reasonable possibility of a causal relationship between Flumist Quadrivalent and the following event: red, scratch and sore. Device Information: Combination Product Report: Yes Product As Reported: FLUMIST QUADRIVALENT Common Device Name: Nasal Spray Procode: CCQ Product Role: Suspect

Other Meds:

Current Illness:

ID: 1787490
Sex: U
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Laboratory test; Result Unstructured Data: nucleolar type cells

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Scleroderma; barely move; It was awful; Stabbing pain at bottoms of feet, and inner wrists; Cat scratch infection and tick infections; Cat scratch infection; Suffering for quite awhile; It was quite disturbing and scary; It was quite disturbing and scary; Other pain; feel as though it messed up my immune system as well; get sick much more often; Stabbing pain at bottoms of feet, and inner wrists/ left shoulder pain; I am drained; Excruciating head pain; Case reference number US-BN-2021-002328 is a spontaneous case report initially received from a consumer via GSK (reference number unknown) on 07-Oct-2021, and concerns a patient of an unknown age. The patient's medical history included headaches, approximately once every few years. The patient's concomitant medication details were not provided. On an unspecified day, approximately six years ago, the patient received the first dose of rabies vaccine (brand name unknown, Batch no. was not provided) at an unknown dose and route of administration, for an unknown indication. On the same day, the patient experienced excruciating head pain (stabbing in one specific area, in back left lower side) which occurred a few hours after the shots. The patient called an emergency room and they said they could not evaluate the patient over the phone. The patient could barely move and was feeling awful. It was reported that it did go away after several hours. The patient also experienced stabbing pain at the bottoms of feet and inner wrists. On an unspecified date, the patient had few more shots to receive but just one dose at a time, rather than several at once, as reported. The patient was still getting headaches and other pain, but it had improved. The patient also had left shoulder pain, all ice pick type stabbing for a few months. The patient had on and off pain, but not as intense. Before that, the patient barely had headaches, maybe once every few years. The patient was feeling better and ended up getting a cat scratch infection and in addition to other symptoms, all of the past pain came back, with full force and had continued ever since. The patient did not get it as often as used to, but it still was happening in the same areas and regularly though it may not be relentless for hours at a time anymore, but sporadic throughout the day. That pain was different than any typical headache or other pain the patient have had in life. The patient also had issues with tick infections. Since then, but with antibiotics (unspecified), all symptoms improved, except the pain that originated the same day as the rabies shots. Stabbing head pain also happened in same exact area. The patient had no doubt the shot caused or triggered that. It seemed to came back when the patient's immunity was low or humidity, but it caused the patient a lot of suffering for quite awhile. It was quite disturbing and scary when it first happened, however the patient got used to it, but was drained. The patient felt as though it messed up immune system as well, since the patient got sick much more often, too. Also, what should had been infections that went away with antibiotics, went into years of treatment. On an unspecified date, the patient had a test that showed nucleolar type cells, that may be linked to scleroderma. The patient went to rheumatologist at the beginning of the problems, but it could take years to diagnose an autoimmune disorder and they sent the patient to a neurologist. It was all years ago, as reported. The reporter did not provide the seriousness and causality assessment, however it was noted that although the patient was not sure what the vaccine caused, the patient had very limited issues before it. Never had chronic, stabling pain and often headaches. The event of scleroderma was assessed as serious due to it's medical significance. No further information was provided.; Reporter's Comments: Headache, arthralgia and asthenia are listed for Rabipur according to the Global Datasheet and USPI, whilst feeling abnormal, movement disorder, pain in extremity, pain, cat scratch, infection, immune system disorder, emotional distress, emotional disorder, fear, illness and scleroderma are unlisted for Rabipur according to the Global Datasheet and USPI. Reportedly, on an unspecified day, approximately six years ago, the patient received the first dose of rabies vaccine at an unknown dose and route of administration, for an unknown indication. On the same day, the patient experienced headache, feeling abnormal, movement disorder, pain in extremity and arthralgia (stabbing pain at the bottoms of feet and inner wrists). Later, on an unspecified date the patient developed arthralgia (left shoulder pain), pain, cat scratch and infection. Then the patient had issues with tick infection and since then, but with antibiotics (unspecified), all symptoms improved, except the pain that originated the same day as the rabies shot. Then, as reported, the patient developed the events of immune system disorder, emotional distress, emotional disorder, fear, asthenia and illness. Later, on an unspecified date, the patient had a test that showed nucleolar type cells, that may be linked to scleroderma. The patient's medical history included headaches. The patient's concomitant medication details were not provided. Due to suggestive temporal relationship and since contributory role of the suspect vaccine cannot be excluded, the causality for the events of headache, feeling abnormal, movement disorder, pain in extremity and arthralgia is assessed as possibly related. The causality for all the other events is assessed as unlikely at the moment, due to missing information and not having a clear temporal relationship between the administration of rabies vaccine and the development of the events. This case is considered serious due to medical significance.; Sender's Comments: Headache, arthralgia and asthenia are listed for Rabipur according to the Global Datasheet and USPI, whilst feeling abnormal, movement disorder, pain in extremity, pain, cat scratch, infection, immune system disorder, emotional distress, emotional disorder, fear, illness and scleroderma are unlisted for Rabipur according to the Global Datasheet and USPI. Reportedly, on an unspecified day, approximately six years ago, the patient received the first dose of rabies vaccine at an unknown dose and route of administration, for an unknown indication. On the same day, the patient experienced headache, feeling abnormal, movement disorder, pain in extremity and arthralgia (stabbing pain at the bottoms of feet and inner wrists). Later, on an unspecified date the patient developed arthralgia (left shoulder pain), pain, cat scratch and infection. Then the patient had issues with tick infection and since then, but with antibiotics (unspecified), all symptoms improved, except the pain that originated the same day as the rabies shot. Then, as reported, the patient developed the events of immune system disorder, emotional distress, emotional disorder, fear, asthenia and illness. Later, on an unspecified date, the patient had a test that showed nucleolar type cells, that may be linked to scleroderma. The patient's medical history included headaches. The patient's concomitant medication details were not provided. Due to suggestive temporal relationship and since contributory role of the suspect vaccine cannot be excluded, the causality for the events of headache, feeling abnormal, movement disorder, pain in extremity and arthralgia is assessed as possibly related. The causality for all the other events is assessed as unlikely at the moment, due to missing information and not having a clear temporal relationship between the administration of rabies vaccine and the development of the events. This case is considered serious due to medical significance.

Other Meds:

Current Illness:

ID: 1787491
Sex: U
Age:
State: WI

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Nerve damage to hands, legs; Unable to walk; Allergic reaction to anthrax shot; On 26SEP2021, a spontaneous report was received from a company representative who provided information discovered on a social media website. The reporter provided a video found on an online social media source which discussed a female of an unknown age that received BioThrax (anthrax vaccine adsorbed) on an unknown date and experienced an allergic reaction to the anthrax shot (PT: Drug hypersensitivity) causing disability due to nerve damage to her hands and legs (PT: Nerve injury) and an inability to walk (PT: Gait inability). The patient is seen on the video as being in a wheelchair. The reporter attributes the patient's allergic reaction, nerve damage, inability to walk and resulting disability as related to the anthrax shot. The outcome of the events were not reported. The patient's medical history and concomitant medication use was not reported. No additional information was available. Company Comment: The Company considers that it is possible that the patient had an allergic reaction as hypersensitivity as it is a known phenomenon that could occur with BioThrax; therefore assessed as "Possible". The assumption that the allergic reaction caused nerve damage to the legs and hands so severe that caused permanent disability is not possible to assess or confirm. It is not know that an allergic reaction could cause neuropathy and although other form of neuropathy like Bell's palsy, has been attributed to COVID 19 and influenza vaccine, it has not been associated to BioThrax nor general neuropathy; therefore, the nerve damage and the inability to walk are considered "Unassessable". More information will be sought.; Sender's Comments: The Company considers that it is possible that the patient had an allergic reaction as hypersensitivity as it is a known phenomenon that could occur with BioThrax; therefore assessed as "Possible". The assumption that the allergic reaction caused nerve damage to the legs and hands so severe that caused permanent disability is not possible to assess or confirm. It is not know that an allergic reaction could cause neuropathy and although other form of neuropathy like Bell's palsy, has been attributed to COVID 19 and influenza vaccine, it has not been associated to BioThrax nor general neuropathy; therefore, the nerve damage and the inability to walk are considered "Unassessable". More information will be sought.

Other Meds:

Current Illness:

ID: 1787493
Sex: U
Age: 71
State: IL

Vax Date: 12/03/2018
Onset Date: 07/20/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: received both Shingrix vaccines, shingles/ suspected vaccination failure; shingles/ Shingles 4-6 times a year; painful; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 74-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (got shingles 4 to 6 times a year, each debilitating). On an unknown date, the patient received the 1st dose of Shingrix. On 3rd December 2018, the patient received the 2nd dose of Shingrix. On 20th July 2021, unknown after receiving Shingrix and 960 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingrix and Shingrix. Additional details were provided as follows: The patient self-reported this case. The patient received both the doses of Shingrix and still got shingles. The patient stated that the shingles she got in July 2021 were more painful which were along the right side of his/her neck moving to behind right ear. The patient also had mild symptoms in September 2021, refer case US2021AMR208041. The patient asked if GSK working on any booster option. This case was considered as suspected vaccination failure as details regarding laboratory test confirming herpes zoster were unknown at the time of reporting.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR208041:same reporter

Other Meds:

Current Illness:

ID: 1787494
Sex: U
Age: 71
State: IL

Vax Date: 12/03/2018
Onset Date: 09/01/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: received both Shingrix vaccines, shingles/ suspected vaccination failure; shingles; painful; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 71-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (4-6 times a year, each debilitating). On an unknown date, the patient received the 1st dose of Shingrix. On 3rd December 2018, the patient received the 2nd dose of Shingrix. In September 2021, unknown after receiving Shingrix and more than 2 years after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not recovered/not resolved. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingrix and Shingrix. Additional details were provided as follows: The patient self-reported this case. The patient received both the doses of Shingrix and still got shingles. For shingles experienced on 20th July 2021, refer case US2021AMR207912. The patient received the shingrix shot and had painful attack, milder one in September 2021. The patient was feeling the signature pain again this morning. The patient had several small, short duration attacks several times since last vaccine and was grateful for the overall effect. The patient asked if GSK working on any booster option. This case was considered as suspected vaccination failure since the details regarding laboratory test confirming shingles were unknown at the time of reporting. This case was linked with US2021AMR207912, reported by the same reporter for the same patient.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR207912:same reporter

Other Meds:

Current Illness:

ID: 1787496
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Suspected vaccination failure; Had the vaccine and still got shingles for the third time; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient had the vaccine and still got shingles for the third time. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and lab test confirmation was unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1787497
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: suspected vaccination failure/I got vaccinated several years back, and currently have what I consider an horrific case of Shingles.; horrific case of Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details provided were as follows: The case was self-reported by the patient. The age at vaccination was not reported. The patient received a dose of Shingles vaccine several years back, and currently experienced a horrific case of Shingles. The patient would not wish this on anyone. The patient hope that the current vaccine would be better than the one he/she got. Follow-up would not be possible as no contact details available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1787503
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: had the shot still gets shingles/ Suspected vaccination failure; shingles; This case was reported by a consumer via Shingrix interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were reported as follows: The age at vaccination was not reported. The patient received the shot still gets shingles. The reporter asked are there any studies that might help. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, laboratory confirmation for shingles and time to onset were unknown.

Other Meds:

Current Illness:

ID: 1787505
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: had both shingle shots/ shingles/ suspected vaccination failure; shingles dark blotchy; dark blotchy; shingles dark; This case was reported by a consumer via Shingrix interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, blotchy and darkened skin. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, blotchy and darkened skin were not recovered/not resolved. It was unknown if the reporter considered the vaccination failure, shingles, blotchy and darkened skin to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient received both Shingles shot and have what looks to shingles dark blotchy. The patient stated no pain was there. The patient asked anything to do or take to make shingles go away. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles and time to onset were unknown.

Other Meds:

Current Illness:

ID: 1787507
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: had shingles for years, and had the shots./ suspected vaccination failure; had shingles for years,; red spot; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and localized erythema. On an unknown date, the outcome of the vaccination failure, shingles and localized erythema were unknown. It was unknown if the reporter considered the vaccination failure, shingles and localized erythema to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient received the shots and had shingles for years. The patient guess that he/she had been lucky. All that the patient ever get was a 2-inch red spot on butt for a week every year. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles and time to onset were unknown.

Other Meds:

Current Illness:

ID: 1787512
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Got vx 2 weeks ago. Now shingles in eye; Now I have shingles in my face; So painful; This case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 3 weeks after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the ophthalmic herpes zoster, shingles and pain were not recovered/not resolved. It was unknown if the reporter considered the ophthalmic herpes zoster, shingles and pain to be related to Shingles vaccine. Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient got vaccinated 2 weeks before the date of reporting and at the time of reporting the patient had shingles in eye and face and stated it was so painful.

Other Meds:

Current Illness:

ID: 1787515
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: had shingles despite both shingles vaccines/ Suspected vaccination failure; shingles on right side; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and COVID-19 VACCINE (COVID 19 VACCINE (MANUFACTURER UNKNOWN)) for prophylaxis. The patient's past medical history included shingles (previously had shingles on right side). Previously administered products included Shingles vaccine. On an unknown date, the patient received the 2nd dose of Shingles vaccine, the 1st dose of Shingles vaccine and COVID 19 VACCINE (MANUFACTURER UNKNOWN). On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient recently had shingles on right side related to the COVID vaccine despite the fact that the patient has had both of the shingles vaccines for a total of 3 shots. The patient stated that look it up online about Shingles and COVID vaccines. The patient stated that the shingles was also a possible side effect of the COVID Vaccine. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles and time to onset were unknown.

Other Meds: Zoster

Current Illness:

ID: 1787516
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: got two shots have Shingles/ Suspected vaccination failure; went to er, shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient received the two Shingles shots a year before the date of reporting and went to the emergency room last Friday and had the Shingles. The patient stated it was horrible. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles was unknown.

Other Meds:

Current Illness:

ID: 1787521
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Suspected vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix. Additional details were provided as follows The age at vaccination was not reported. After receiving Shingrix, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding time to onset and laboratory confirmation of shingles were not provided. On 9th October 2021, the patient got shingles again, refer case US2021AMR210317. The patient asked if there was something wrong with vaccines.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR210317:Same reporter.

Other Meds:

Current Illness:

ID: 1787522
Sex: U
Age:
State:

Vax Date:
Onset Date: 10/09/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Had 2 shingle vx and today got shingles again/ Suspected vaccination failure; And today got shingles again; This case was reported by a consumer via (Shingrix interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (occurred on an unknown date, refer case US2021AMR210315). On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On 9th October 2021, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient received 2 shingle vaccines and again on the day of reporting got shingles. The reporter asked was there something wrong with vaccines. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles and time to onset were unknown.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR210315:Same reporter.

Other Meds:

Current Illness:

ID: 1787523
Sex: U
Age:
State:

Vax Date:
Onset Date: 02/01/2020
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: 2 shingles vx 3 years ago and last year got shingles/ suspected Vaccination failure; Last year got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In February 2020, more than a year after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient received the two shingle vaccines 3 years before the date of reporting and last year the patient got shingles in February 2020. The patient asked was there something wrong with the vaccines why was this happening. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles was unknown. For 2nd occurrence of shingles refer linked case US2021AMR210325, reported by same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR210325:Same reporter.

Other Meds:

Current Illness:

ID: 1787524
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: 2 shingles vx 3 years ago, just diagnosed with shingles again/ suspected Vaccination failure; Just diagnosed with shingles again; This case was reported by a consumer via (Shingrix interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (occurred in February 2020, refer case US2021AMR210321). On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, more than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient received the two shingle vaccines 3 years before the date of reporting and have just been yet again diagnosed with shingles. The patient asked was there something wrong with the vaccines why was this happening. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles was unknown.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR210321:Same reporter.

Other Meds:

Current Illness:

ID: 1787526
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: experienced shingles/Suspected vaccination failure; Shingles; rash on side of the body, face, along nerve path; Blisters; Scabs; Pain; Itching; Tingling; Numbness; Fever; Headache; Not feeling well; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, rash, blister, scab, pain, pruritus, tingling, numbness, fever, headache and feeling unwell. On an unknown date, the outcome of the vaccination failure, pain, pruritus, tingling, numbness, fever, headache and feeling unwell were unknown and the outcome of the shingles, rash, blister and scab were recovered/resolved. It was unknown if the reporter considered the vaccination failure, shingles, rash, blister, scab, pain, pruritus, tingling, numbness, fever, headache and feeling unwell to be related to Shingrix. Additional details were reported as follows: This case was reported by patients wife. The age at vaccination was not reported. The patient experienced all symptoms listed except gastrointestinal issues. The listed symptoms were as follows: Shingles typically produces a painful rash that blisters and scabs over in 7 to 10 days and clears up within 2 to 4 weeks. The reporter stated that 1 to 5 days before the rash appears, people might experience pain, itching, tingling, or numbness in the area where the rash would develop. Other symptoms at this time could include fever, headache, and a sense of not feeling well. The rash usually erupts in a single stripe on either the left or right side of the body, or sometimes the face, along a nerve path. The reporter stated that it could develop on the arm, thigh, head and even the ear or eye. It was most common on the chest and abdomen. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided. The follow-up would not possible as contact information not available.

Other Meds:

Current Illness:

ID: 1787527
Sex: U
Age:
State: TX

Vax Date: 12/01/2020
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: shingles, both doses of Shingrix/Suspected Vaccination failure; I had an outbreak/second outbreak; not as inflamed; just as painful; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (suffered from shingles outbreaks for years, isolated to a single spot about the size of a quarter just above my right eye), pain and inflammation. Previously administered products included Shingles vaccine (had the original shingles vaccine when it first came out). In December 2020, the patient received the 2nd dose of Shingrix. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, inflammation and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, inflammation and pain were not recovered/not resolved. It was unknown if the reporter considered the vaccination failure, shingles, inflammation and pain to be related to Shingrix and Shingrix. Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient had suffered from shingles outbreaks for years and outbreaks was mild by most standards. They are isolated to a single spot about the size of a quarter just above right eye. The concern of course was the proximity to eyes so patient watch it closely. The patient had the original shingles vaccine when it first came out and then both doses of Shingrix. The second vaccination was approximately in December 2020 and was everything was fine until about 6 weeks before the date of reporting, when patient had an outbreak. The patient experienced, less than 6 weeks later, second outbreak. The outbreaks was not as inflamed as they were prior to the vaccine, but they remain just as painful. The patient wanted to report the lack of effectiveness for records. This case was considered as suspected vaccination failure since the details regarding laboratory test confirming shingles was unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1787530
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: suspected vaccination failure; shingles twice; This case was reported by a consumer via (Shingrix interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient had shingles twice after being vaccinated for shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided

Other Meds:

Current Illness:

ID: 1787532
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Got the shot, Get it/ Suspected vaccination failure; Get it under the skin; This case was reported by a consumer via (Facebook) interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovering/resolving. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the shingle shot and still got shingles again but it stayed under the skin this time and it does last a long while. The patient was just getting over shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1787533
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Suspected vaccination failure; Bad case of shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient was reporter's sister in law. The age at vaccination was not reported. The reporter stated that the patient got shingles shot and had a bad case of shingles after it. The reporter was afraid to get shingles shot. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided

Other Meds:

Current Illness:

ID: 1787534
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Suspected vaccination failure/ Can still get shingles even if you get the shot; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got shingles even though he/she got the shot. The patient stated that the shot was supposed to help with symptoms and the patient thought it did not work. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1787535
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: got the shingles after second shingles vaccine/Suspected vaccination failure; shingles/ It spread on the inside of right arm; it blistered; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 7 months after receiving Shingles vaccine and unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and blister. On an unknown date, the outcome of the vaccination failure, shingles and blister were unknown. It was unknown if the reporter considered the vaccination failure, shingles and blister to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient got the shingles 7 months after the he/she got the 2nd shingles vaccine. The patient had no pain at all, no itching. The patient stated that it just blistered and spread on the inside of right arm. The patient stated that dermatologist said it was shingles and prescribed medication. This case was considered as suspected vaccination failure, since the details regarding the laboratory confirmation of shingles were not provided. The follow up would not possible as contact information was not available.

Other Meds:

Current Illness:

ID: 1787536
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: suspected vaccination failure; Round 1 was 3 years after the shingles vaccine/shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The case was reported by the consumer for herself/himself. The age at vaccination was not reported. The patient experienced 1st round of shingles 3 years after the Shingles vaccine. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule and laboratory confirmation for shingles were not provided. For the tolerance of the 2nd round of shingles, refer linked case US2021AMR211140, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR211140:same reporter

Other Meds:

Current Illness:

ID: 1787537
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: suspected vaccination failure; got shingles; burns; hurts; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included chickenpox (had as a child). On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, burning sensation and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, burning sensation and pain were not recovered/not resolved. It was unknown if the reporter considered the vaccination failure, shingles, burning sensation and pain to be related to Shingles vaccine. Additional details were provided as follows: The patient reported this case. The age at vaccination was not reported. The patient received Shingles vaccine, few years before the date of reporting. Three years before the date of reporting, the patient got shingles. The patient stated that, it still burns and hurt at the time of reporting. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1787538
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: suspected vaccination failure; Including my L eye; lost all hearing in L ear; shingles on the L side of my face/2nd time of shingles after the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (1st round of shingles was 3 years after the shingles vaccine, refer case US2021AMR211136). On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant), deafness unilateral (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster, deafness unilateral and shingles were recovered/resolved. It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, deafness unilateral and shingles to be related to Shingles vaccine. Additional details were provided as follows: The case was reported by the consumer for herself/himself. The age at vaccination was not reported. At the time of reporting, the patient just finished 2nd time round of shingles. The patient stated that It was a miserable disease. The patient said, this time they were on the left side of the patient face, including left eye and lost all hearing in left ear. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule and laboratory confirmation for shingles were not provided.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR211136:same reporter

Other Meds:

Current Illness:

ID: 1787541
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter ; Sender's Comments: US-GLAXOSMITHKLINE-US2021201400:Original Case : US2021201400, same reporter US-GLAXOSMITHKLINE-US2021AMR212309:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212283:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212310:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212311:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212284:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212285:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212312:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212313:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212286:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212287:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212314:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212288:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212289:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212315:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212316:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212290:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212317:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212318:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212291:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212292:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212319:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212320:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212293:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212294:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212321:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212295:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212322:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212323:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212296:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212297:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212324:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212324:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212298:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212299:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212326:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212327:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212300:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212301:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212328:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212302:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212303:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212304:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212305:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212306:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212280:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212307:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212308:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212337:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212281:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR212282:Original Case : US2021AMR211145,same reporter US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787543
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: suspected vaccination failure; shingles; agony with nerve pain; can't even stand a shirt; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and an unknown time after starting lidocaine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, nerve pain and activities of daily living impaired. The patient was treated with lidocaine. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, nerve pain and activities of daily living impaired were not recovered/not resolved. It was unknown if the reporter considered the vaccination failure, shingles, nerve pain and activities of daily living impaired to be related to Shingles vaccine. Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not reported. The patient was in agony with nerve pain that had lasted for 5 months. The patient was now on Lidocaine cream. The reporter asked if there was any pill medication. The patient got the vaccine and got a really bad case of shingles. The patient could not even stand a shirt and had to make a tent in bed so the covers won't touch him. Three trips to the doctor and no relief. The reporter and the patient were both about nuts with this. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1787544
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: shingles in her eye; This case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant). On an unknown date, the outcome of the ophthalmic herpes zoster was unknown. It was unknown if the reporter considered the ophthalmic herpes zoster to be related to Shingles vaccine. Additional details were provided as follows: The patient was the reporter's neighbor. The age at vaccination was not reported. The patient received shingles shot and right after got shingles in right eye.

Other Meds:

Current Illness:

ID: 1787549
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Got the Shot and got shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she got Shingles shot and one year late got shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1787550
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: have gotten the shot twice and I still get small patches on my butt\ suspected vaccination failure; still get small patches on my butt; small patches on my butt; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and patchy rash. On an unknown date, the outcome of the vaccination failure, shingles and patchy rash were unknown. It was unknown if the reporter considered the vaccination failure, shingles and patchy rash to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles shot twice and still got small patches on butt. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1787551
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: have had shingles and the shots\ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles shots about five years ago and had shingles. The patient asked he/she could had Shingles shots again. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1787552
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: got both shots, but got shingles\ suspected vaccination failure; got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she got both Shingles shot but got shingles anyway. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1787553
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter. ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:Same reporter

Other Meds:

Current Illness:

ID: 1787554
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter. ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:Same reporter

Other Meds:

Current Illness:

ID: 1787555
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter. ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:Same reporter

Other Meds:

Current Illness:

ID: 1787556
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter. ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:Same reporter

Other Meds:

Current Illness:

ID: 1787557
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:Same reporter

Other Meds:

Current Illness:

ID: 1787558
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787559
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787560
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787561
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787562
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter. ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787563
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787564
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter. ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787565
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter. ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787566
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter. ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787567
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

ID: 1787568
Sex: U
Age:
State: MO

Vax Date: 09/22/2021
Onset Date: 09/22/2021
Rec V Date: 10/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: received Fluarix expired dose; This case was reported by a pharmacist and described the occurrence of expired vaccine used in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) (batch number Z7275, expiry date 30th June 2021) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 22nd September 2021, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On 22nd September 2021, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received expired dose of Fluarix season 2020-2021, which led to expired vaccine used. The patient was revaccinated with correct Fluarix Tetra 2021-2022 season. The VARES report was filled by facility for the patient. The reporter confirmed that, there were 52 patients who received expired dose of vaccine and this is one of 52 cases, reported by the same reporter. ; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR201274:same reporter

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am